Glioblastoma (GBM) is the most common malignant brain tumor, being highly invasive and not responsive to standard treatment (surgery, radiotherapy, and chemotherapy). Moreover, a major determinant of the high lethality of GBM is the presence of self-renewing, tumorigenic glioblastoma stem-like cells (GSCs) that threateningly support the development and the progressive growth of tumors.
Recent studies in vivo have demonstrated the anti-neoplastic effects of CNF1, a bacterial protein that specifically modulates regulatory proteins, thus affecting fundamental cellular processes. CNF1 is detrimental for GBM cells since it is able to block cell proliferation, leading to cell death, while displaying a beneficial activity on peritumoral neurons, enhancing their plasticity and maintaining their functional properties. However, it is unknown whether CNF1 could act on GSCs, and the mechanism exploited by CNF1 to act on GBM cells is also not well understood. To address this question, we will analyze the effect of CNF1 on different GSCs and GBM cell lines in the activity and the mechanism used to induce cytotoxicity, with the final goal of verifying if CNF1 can represent a potential new strategy against incurable brain tumors.
The proposed study could lead to the identification of a new potential successful strategy for the treatment of GBM. To date, GBM remains incurable, due to its heterogeneity and complex pathogenesis, and affected individuals have a very poor life expectancy, with a median survival of 15 months. In the present research, we will establish whether the bacterial protein CNF1 could act on GSCs and GBM cell lines, and, consequently, the mechanism underlying will be defined. Our hypothesis is that CNF1 acts on GSCs and, in general, on GBM via the rewiring of mitochondrial metabolism and ROS production. CNF1 is being increasingly recognized as a promising potential drug for a certain number of pathologic conditions of the central nervous system. In fact, it has been already proven that CNF1 acts on mitochondria, the powerhouse of the cell, and that it restores the correct behavior in a plethora of diseases in which mitochondria are affected. We have already reported that CNF1 is able to improve the behavioral phenotype and rescue cognitive deficit, in both Rett syndrome and Alzheimer’s disease mouse models, counteracting mitochondrial dysfunction and favoring cell energy restore. In addition, in a mouse model of epileptic seizures, where mitochondrial dysfunctions are considered a potential cause, CNF1 enhances brain energy and counteracts spontaneous epileptiform phenomena. Moreover, recent studies have demonstrated anti-neoplastic effects of CNF1 in a murine glioma model, blocking cell proliferation and leading to cell death, and significantly prolonging animal survival, with no obvious toxicity. Furthermore, CNF1 potently reduces tumor volume in mice, displaying a beneficial activity on peritumoral neurons, enhancing their plasticity and maintaining their functional properties. The maintenance of behavioral functions has been demonstrated after treatment with CNF1 at a symptomatic stage. These different results in vitro and in vivo point at mitochondria, stimulated by CNF1, as the key players. Therefore, we hypothesize that CNF1 acts on GSCs and, in general, on GBM via the rewiring of mitochondrial metabolism and ROS production.
We have identified three aims to be developed in 12 months.
Currently, finding a treatment to totally eradicate GBM is an important achievement for health care. We are confident that to study the mechanisms by which CNF1 acts on GBM will help this goal achievement. Our studies will improve the knowledge of CNF1 activity on GBM and consequently, the scientific community will be provided with new tools to pursue the development of a novel potential drug for a so devastating disease. Indeed, a new therapeutic option in an oncological ambit should bring benefits to cancer patients and also economic output in terms of healthcare services.
Gliomas are a diverse group of malignant primary neoplasms of the central nervous system (CNS), derived from glial cells, with a worldwide incidence of approximately 7 out of 100,000 individuals per year. According to the recent World Health Organization (WHO) classification, glioblastoma (GBM) is identified as WHO grade IV glioma and is the most common and aggressive malignant brain tumor, characterized by tissue ischemic necrosis, strong invasiveness, and microvascular proliferation. GBM is not responsive to standard treatment (surgery and combined radio- and chemotherapy), thus affected individuals having a very poor life expectancy. A major determinant of the high lethality of GBM is the presence of self-renewing, tumorigenic glioblastoma stem-like cells (GSCs) characterized by a relative quiescence, which renders them resistant to conventional therapies that target the proliferative population, supporting the development and progressive growth of tumors.
The cytotoxic necrotizing factor 1 (CNF1), a bacterial protein produced by some pathological strains of Escherichia coli, specifically modulates Rho GTPases, thus affecting fundamental cellular processes. CNF1, in fact, promotes new activities mainly linked to the actin cytoskeleton remodeling and to the activation of transcription factors. It has already proven that the protein causes changes in the mitochondrial architecture that mainly consists in the formation of a complex network of elongated mitochondria, and in the enhancement of mitochondrial activity that leads to an increase in cellular ATP content. Interestingly, the CNF1 activity on mitochondria allows CNF1 to restore the correct behavior in a plethora of diseases in which mitochondria are affected. In fact, CNF1 is able to improve the behavioral phenotype and rescue cognitive deficit in mouse models of both Rett syndrome and Alzheimer’s disease, where CNF1 is able to counteract mitochondrial dysfunction and favor cell energy restore. In addition, in a mouse model of epileptic seizures, where mitochondrial dysfunctions are considered a potential cause, CNF1 enhances brain energy and counteracts spontaneous epileptiform phenomena. Recent studies have demonstrated the anti-neoplastic effects of CNF1 in a mouse model of glioma. CNF1 is detrimental for GMB cells since it is able to block cytodieresis in proliferating cells, leading them to senescence and death, while displaying a beneficial activity on peritumoral neurons, enhancing their plasticity and maintaining their functional properties. These abilities point at CNF1 as a possible new strategy for the treatment of brain tumors.
However, it is unknown whether CNF1 could act on GSCs and also the mechanism exploited by CNF1 to act on GBM is not well understood. To address this question, we will analyze the effect of CNF1 on different cell lines of GBM and GSCs with the aim of studying the CNF1 activity and in particular, the mechanism used to induce cytotoxicity.
We hypothesize that CNF1 acts on GSCs and, in general, on GBM via the rewiring of mitochondrial metabolism and ROS production. We have already reported, in fact, that CNF1 acts on mitochondria and restores the correct behavior in a plethora of diseases in which mitochondria are affected.
Our studies will improve the knowledge of CNF1 activity on GBM, thus rendering CNF1 a potential and innovative tool against incurable brain tumors. Thus, to verify the hypothesis underlying this project, we have identified three aims to be exploited in 12 months:
All three aims will be in charge of ISS – PI and Co-investigator.
We expect that CNF1 will exert its activity also on GSCs, causing an alteration in cell metabolism and ROS production in both human GSCs and GBM cells, ultimately leading to the death of cells.
Currently, finding a treatment to totally eradicate GBM could be an important achievement for health care. The proposed study, by establishing whether CNF1 could act on GSCs, will provide greater insight into the mechanism used by CNF1 to affect GBM cells, and the research findings could be a step forward the clinical use of CNF1 as an innovative treatment against a so devastating disease, with a great impact in reducing mortality in GBM.
The investigators and all the researchers involved in the study have the skills and competencies needed to meet the research goals, with long-lasting experience in the field of bacterial toxins, glioma, mitochondrial analyses as well as cellular and molecular pathways dissection.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer gravida non felis non euismod. Fusce finibus aliquet consequat. Nam ac metus bibendum, iaculis purus sed, suscipit ligula. Proin et nisi libero. Mauris non urna urna. Nullam augue eros, fringilla sed mauris vitae, porta tincidunt risus. Aliquam sed tincidunt sem. Quisque lacinia quam tortor, imperdiet efficitur odio iaculis in. Sed ultricies condimentum volutpat. Vivamus dignissim faucibus porta.
Curabitur ut ipsum non odio malesuada vulputate. Morbi maximus, est eu lobortis molestie, tortor sapien hendrerit nisi, in cursus odio diam ut odio. Fusce pulvinar volutpat velit. Aliquam erat volutpat. Integer rhoncus mollis suscipit. Praesent non ipsum mollis, finibus nunc a, scelerisque nibh. In feugiat iaculis velit, eu semper lacus dignissim nec. Praesent vitae nisi leo. Cras venenatis dictum magna ut semper. Sed eget eros nibh. Sed vitae quam sed dolor faucibus elementum. Curabitur interdum porttitor finibus. Nullam tincidunt odio lectus, sit amet rhoncus libero dapibus sed. Sed mollis egestas enim, vel porta tortor volutpat eget.
Morbi orci urna, ornare non pretium eget, pulvinar eget magna. Ut consectetur efficitur varius. Fusce ac aliquet mauris, at mattis ligula. Quisque est libero, interdum id orci et, ornare luctus diam. Proin commodo lectus id accumsan blandit. Nulla eu turpis interdum, luctus ante ac, imperdiet tellus. In semper enim eu tristique aliquam.
Integer fermentum vestibulum lacinia. Duis id aliquam nibh, ut mattis leo. Nulla ac dui at sapien posuere facilisis ut quis ex. Aliquam vestibulum blandit tristique. Integer pretium dui ac nulla accumsan, et finibus velit euismod. Proin placerat, nunc eu sodales facilisis, tellus justo efficitur risus, non blandit diam nulla ac ligula. Aliquam ullamcorper quam leo, porttitor dictum ex tempor ac. Ut efficitur, justo et auctor volutpat, ex ex pulvinar est, sed consequat turpis leo nec ipsum. Nunc tempor, turpis ut ullamcorper tempor, dolor dui varius dui, et congue quam nisi vel nunc.
Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Donec faucibus, turpis sit amet maximus dapibus, sapien nisl bibendum turpis, pharetra commodo tellus libero vel nulla. Sed nec velit viverra, congue sapien et, gravida libero. Proin eget ante eget turpis egestas accumsan. Aliquam arcu nibh, aliquam rhoncus vulputate in, pellentesque at sem. Maecenas cursus tempus nibh id tempus. Mauris dolor sapien, lacinia sit amet condimentum at, dapibus eget lectus. Phasellus vel pellentesque ex. Nunc aliquam in ligula at tristique. In mollis suscipit felis eu finibus. Nullam non dignissim nibh, nec suscipit ex. Suspendisse tincidunt et mauris id finibus. Aliquam vehicula a sem quis venenatis.
Suspendisse leo odio, rutrum et viverra ut, consequat finibus enim. Vivamus dolor nisl, viverra eu egestas vel, blandit in nulla. Curabitur auctor purus non est volutpat bibendum. Proin fringilla magna sed metus maximus, in dictum neque suscipit. Sed ornare ut mi ut sodales. Nulla efficitur urna nunc, non molestie nunc egestas ut. Nunc arcu lorem, semper ut tincidunt ac, eleifend quis elit.
Sed at tortor et tortor tincidunt feugiat id in dui. Vivamus eget justo nisl. Aenean congue laoreet nisl a elementum. Nunc consectetur velit non ligula sollicitudin, quis eleifend urna sollicitudin. Sed tincidunt, nisl quis varius venenatis, dui massa condimentum tellus, sed sollicitudin diam magna mollis augue. Sed venenatis commodo purus id malesuada. Aenean volutpat elit vel gravida consectetur. Vestibulum diam quam, lacinia ac tortor eget, tincidunt dapibus dui. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin nisl leo, pretium sed arcu imperdiet, hendrerit sollicitudin sem. Duis non magna at nunc sagittis ullamcorper a id est. Maecenas cursus nisl in faucibus hendrerit.
Sed hendrerit vitae purus et tempor. Aenean vitae varius velit. Nullam aliquet ipsum elit. Mauris vestibulum purus et metus imperdiet, quis gravida eros pretium. Curabitur rutrum nunc vitae tincidunt condimentum. Aenean sit amet augue velit. Nunc tristique quis lorem id pharetra. Pellentesque sollicitudin, eros sed egestas rutrum, nulla nisl sodales elit, ut imperdiet nunc lectus sit amet nulla. Ut malesuada finibus libero. Curabitur mi dolor, sollicitudin quis bibendum quis, dictum sed enim.
Pellentesque nibh erat, egestas sit amet sagittis malesuada, rhoncus at neque. Mauris maximus commodo tortor, non egestas magna finibus vitae. Sed hendrerit nulla vel venenatis tempor. Suspendisse tristique tincidunt libero et placerat. Nam tincidunt condimentum lorem, vel pharetra est iaculis sed. Nullam ac tincidunt orci. Quisque pharetra ut sem sit amet aliquam. Phasellus risus libero, varius in condimentum vel, commodo id ipsum. Aliquam in metus cursus, mattis diam ut, aliquam magna. Suspendisse facilisis dui et orci varius, suscipit facilisis augue dapibus. In eget nibh ipsum. Suspendisse eget pharetra est, quis condimentum felis. Fusce scelerisque congue libero, sed aliquam mi elementum a. Etiam scelerisque ante non auctor porta. Nam eu nunc id ex finibus dictum. Praesent dui ex, dictum ac massa eget, rutrum gravida nisi.
Sed egestas arcu in dui euismod, eget faucibus massa iaculis. Etiam efficitur lectus et purus lobortis, ac blandit eros rutrum. Proin bibendum consectetur leo vel gravida. Etiam et ultricies sapien. Nam lacinia tellus erat, id facilisis est consequat et. Morbi quis risus in neque iaculis pharetra ut consectetur libero. Aenean feugiat tempor mi eu posuere.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer gravida non felis non euismod. Fusce finibus aliquet consequat. Nam ac metus bibendum, iaculis purus sed, suscipit ligula. Proin et nisi libero. Mauris non urna urna. Nullam augue eros, fringilla sed mauris vitae, porta tincidunt risus. Aliquam sed tincidunt sem. Quisque lacinia quam tortor, imperdiet efficitur odio iaculis in. Sed ultricies condimentum volutpat. Vivamus dignissim faucibus porta.
Curabitur ut ipsum non odio malesuada vulputate. Morbi maximus, est eu lobortis molestie, tortor sapien hendrerit nisi, in cursus odio diam ut odio. Fusce pulvinar volutpat velit. Aliquam erat volutpat. Integer rhoncus mollis suscipit. Praesent non ipsum mollis, finibus nunc a, scelerisque nibh. In feugiat iaculis velit, eu semper lacus dignissim nec. Praesent vitae nisi leo. Cras venenatis dictum magna ut semper. Sed eget eros nibh. Sed vitae quam sed dolor faucibus elementum. Curabitur interdum porttitor finibus. Nullam tincidunt odio lectus, sit amet rhoncus libero dapibus sed. Sed mollis egestas enim, vel porta tortor volutpat eget.
Morbi orci urna, ornare non pretium eget, pulvinar eget magna. Ut consectetur efficitur varius. Fusce ac aliquet mauris, at mattis ligula. Quisque est libero, interdum id orci et, ornare luctus diam. Proin commodo lectus id accumsan blandit. Nulla eu turpis interdum, luctus ante ac, imperdiet tellus. In semper enim eu tristique aliquam.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer gravida non felis non euismod. Fusce finibus aliquet consequat. Nam ac metus bibendum, iaculis purus sed, suscipit ligula. Proin et nisi libero. Mauris non urna urna. Nullam augue eros, fringilla sed mauris vitae, porta tincidunt risus. Aliquam sed tincidunt sem. Quisque lacinia quam tortor, imperdiet efficitur odio iaculis in. Sed ultricies condimentum volutpat. Vivamus dignissim faucibus porta.
Curabitur ut ipsum non odio malesuada vulputate. Morbi maximus, est eu lobortis molestie, tortor sapien hendrerit nisi, in cursus odio diam ut odio. Fusce pulvinar volutpat velit. Aliquam erat volutpat. Integer rhoncus mollis suscipit. Praesent non ipsum mollis, finibus nunc a, scelerisque nibh. In feugiat iaculis velit, eu semper lacus dignissim nec. Praesent vitae nisi leo. Cras venenatis dictum magna ut semper. Sed eget eros nibh. Sed vitae quam sed dolor faucibus elementum. Curabitur interdum porttitor finibus. Nullam tincidunt odio lectus, sit amet rhoncus libero dapibus sed. Sed mollis egestas enim, vel porta tortor volutpat eget.